AI assistant
ORAGENICS INC — Director's Dealing 2008
Jan 31, 2008
35380_dirs_2008-01-31_8f015316-1551-45f9-a5d3-2dab5dc451f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ORAGENICS INC (oni)
CIK: 0001174940
Period of Report: 2008-01-11
Reporting Person: HAWES GEORGE T (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-01-11 | warrants | $0.44 | P | 587500 | Acquired | 2008-02-08 | common stock (587500) | Direct |
| 2008-01-28 | warrants | $0.44 | P | 1000000 | Acquired | 2008-08-08 | common stock (1000000) | Direct |
| 2008-01-28 | warrants | $0.44 | P | 100000 | Acquired | 2008-08-08 | common stock (100000) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-employee Director Options | $0.74 | 2011-09-08 | common stock (65000) | 65000 | Direct |
Footnotes
F1: These warrants were orginally issued to the Reporting Person on March 6, 2006 at an exercise price of $0.60 per share. On January 11, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period fron January 11, 2008 to February 8, 2008, which is the expiration date.
F2: These warrants were originally issued to the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 during the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 per share during the remainder of the warrant term.
F3: These warrants were originally issued to the spouse of the Reporting Person on August 8, 2007 at an exercise price of $0.58 per share. On January 28, 2008, the Board of Directors of the Company reduced the per share exercise price to $0.44 for the period from January 28, 2008 to February 29, 2008. After such period, the per share exercise price reverts back to $0.58 for the remainder of the warrant term.
F4: The Reporting Person disclaims beneficial ownership interest of such securities.